Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-12-10
1998-03-17
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514529, 514530, 514531, 514546, A01N 3702, A61K 31225
Patent
active
057287333
ABSTRACT:
Disclosed is the novel use of N-acyl-N,N',N'-ethylene-diaminetriacetic acids and N-acyl-N,N',N'-(ethylenedioxy) diethylenedinitrilotriacetic acids as active ingredients in preventative as well as therapeutic topical compositions to promote exfoliation and alleviate symptoms of skin conditions caused by abnormal keratinization.
REFERENCES:
patent: 3879537 (1975-04-01), Van Scott et al.
patent: 4105783 (1978-08-01), Yu et al.
patent: 4363815 (1982-12-01), Yu et al.
patent: 4386104 (1983-05-01), Nazzaro-Porro
patent: 4885282 (1989-12-01), Thornfeldt
patent: 4973473 (1990-11-01), Schneider et al.
patent: 5084270 (1992-01-01), Ciaudelli
patent: 5177243 (1993-01-01), Parker
patent: 5191081 (1993-03-01), Parker
patent: 5191106 (1993-03-01), Parker
patent: 5250728 (1993-10-01), Parker et al.
patent: 5258391 (1993-11-01), Van Scott et al.
patent: 5284972 (1994-02-01), Parker et al.
patent: 5385938 (1995-01-01), Yu et al.
patent: 5385943 (1995-01-01), Nazzaro-Porro
patent: 5407958 (1995-04-01), Heath et al.
Avon Products Inc.
Cook Rebecca
LandOfFree
N-acyl-ethylene triacetic composition for treating abnormal kera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-acyl-ethylene triacetic composition for treating abnormal kera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acyl-ethylene triacetic composition for treating abnormal kera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-958107